Tag: boston scientific
October 19, 2017
BioSig Technologies Advances Towards Commercialization into the Global Electrophysiology Market Estimated to Reach $8.2 Billion by 2022
BioSig Technologies, Inc. (BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need within...
April 25, 2017
BioSig Technologies Provides Shareholder Update
BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address...
April 7, 2017
BioSig Technologies Completes Private Placement
BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address... March 24, 2017
Neovasc Posts Financial Results For 2016
Neovasc (TSX:NVCN) announced their financial results for 2016 and their fourth quarter.
March 17, 2017
BioSig Technologies Announces Strategic Partnership with Mayo Clinic
BioSig Technologies (OTCQB:BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet...
January 9, 2017
Medical Device Trends 2017: Doubts on Policy and the Rise of Cyber Threats
A market currently estimated to be worth $389 billion worldwide medical devices enjoyed a positive developing year in 2017. However,... November 22, 2016